Drug Pipeline

Enavogliflozin Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 4
2
Phase 3
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06399835 Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis Type 2 Diabetes Recruiting
NCT06528262 Effect of Enavogliflozin on Recurrence of Atrial Fibrillation After Catheter Ablation Atrial Fibrillation Recruiting
Phase 3
NCT06027307 Enavogliflozin Outcome Trial in Functional Tricuspid Regurgitation Tricuspid Regurgitation Active, Not Recruiting
Sponsors Running Enavogliflozin Trials
Asan Medical Center (1) Seoul National University Bundang Hospital (1) Yonsei University (1)
Disease Areas
Heart Failure (1) Type 2 Diabetes (1) Diabetes (1) Atrial Fibrillation (1)
Get alerts when Enavogliflozin trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free